Portland, OR — (PRESS RELEASE JET) — 10/13/2017 — The cardiovascular and thoracic disease application segment is projected to maintain its lead throughout the analysis period owing to increase in the number of medical imaging services and technological advancements. In addition, technological innovations in the imaging industry have facilitated the development of cost-effective and smaller point-of-care ultrasound systems for cardiac evaluation.

Medical/Diagnostic Imaging Market is expected to garner $45.0 billion by 2022, registering a CAGR of 5.1% during the forecast period 2015-2022. Medical/Diagnostic Imaging refers to the use of different imaging modalities to get visual representations of the interior of a body for diagnostic and therapeutic purposes.

Get the sample copy for free: Click Here

Geographically, the Asia-Pacific region accounted for the majority of the share in the medical/diagnostic imaging market in 2015, and is expected to maintain this lead throughout the forecast period. This is mainly attributed to the improving healthcare infrastructure and healthcare expenditures in the emerging markets (such as India and China) to overcome the unmet medical needs in these countries.

Make a purchase enquiry: Click Here

The market is expected to gain traction in the developing regions of Asia-Pacific and other LAMEA nations. The reasons for the unparalleled market growth are large undiagnosed patient population, rapid urbanization, increase in disposable income, improved government funding towards chronic disorders, and growing awareness about early diagnosis of diseases.


By Product Type

-Computed Tomography (CT) Scanners
-X-ray Imaging Systems
-Magnetic Resonance Imaging (MRI) Systems

By Application

-Obstetrics/Gynecology (OB/GYN) Health
-Orthopedics and Musculoskeletal
-Neuro and Spine
-Cardiovascular and Thoracic
-General Imaging
-Breast Health

Powered by WPeMatico